{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:01:11Z","timestamp":1775869271248,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ajp.2012.10.004","type":"journal-article","created":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T03:30:40Z","timestamp":1353123040000},"page":"157-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Paroxetine in the treatment of dysthymic disorder without co-morbidities: A double-blind, placebo-controlled, flexible-dose study"],"prefix":"10.1016","volume":"6","author":[{"given":"Arun V.","family":"Ravindran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Bhatla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi N.","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia L.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2012.10.004_bib0005","series-title":"Dysthymic Disorder","first-page":"1","article-title":"Towards a definition of dysthymia: boundaries with personality and mood disorders","author":"Akiskal","year":"1990"},{"issue":"1\u20132","key":"10.1016\/j.ajp.2012.10.004_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0327(00)00347-5","article-title":"Dysthymia and cyclothymia in psychiatric practice a century after Kraepelin","volume":"62","author":"Akiskal","year":"2001","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.ajp.2012.10.004_bib0015","series-title":"Dysthymia and the Spectrum of Chronic Depressions","author":"Akiskal","year":"1997"},{"key":"10.1016\/j.ajp.2012.10.004_bib0020","series-title":"The Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"12","key":"10.1016\/j.ajp.2012.10.004_bib0025","first-page":"2163","article-title":"The Hamilton Depression Rating Scale: has the gold standard become a lead weight?","volume":"161","author":"Bagby","year":"2004","journal-title":"American Journal of Proctology"},{"key":"10.1016\/j.ajp.2012.10.004_bib0030","first-page":"126","article-title":"The influence of comorbid anxiety disorders on outcome in major depressive disorder","volume":"31","author":"Baldwin","year":"2009","journal-title":"Mediocographia"},{"issue":"1","key":"10.1016\/j.ajp.2012.10.004_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00004850-200015010-00007","article-title":"The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia","volume":"15","author":"Ball\u00fas","year":"2000","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.ajp.2012.10.004_bib0040","first-page":"405","article-title":"Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18\u201359 years","volume":"50","author":"Barrett","year":"2001","journal-title":"Journal of Family Practice"},{"key":"10.1016\/j.ajp.2012.10.004_bib0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1016\/j.ajp.2012.10.004_bib0050","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4088\/JCP.v65n0813","article-title":"Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder","volume":"65","author":"Boylan","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.ajp.2012.10.004_bib0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0165-0327(01)00343-3","article-title":"Sertraline and\/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs","volume":"68","author":"Browne","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1016\/j.ajp.2012.10.004_bib0060","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1017\/S0033291799001324","article-title":"The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis","volume":"29","author":"De Lima","year":"1999","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1016\/j.ajp.2012.10.004_bib0065","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"issue":"Suppl.","key":"10.1016\/j.ajp.2012.10.004_bib0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0447.1994.tb05877.x","article-title":"Historical and nosological aspects of dysthymia","volume":"383","author":"Freeman","year":"1994","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"10.1016\/j.ajp.2012.10.004_bib0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"British Journal of Social & Clinical Psychology"},{"issue":"8","key":"10.1016\/j.ajp.2012.10.004_bib0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4088\/JCP.v60n0802","article-title":"The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management","volume":"60","author":"Haykal","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2012.10.004_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00004850-200405000-00004","article-title":"Citalopram in the treatment of dysthymic disorder","volume":"19","author":"Hellerstein","year":"2004","journal-title":"International Clinical Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.ajp.2012.10.004_bib0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2011.12.008","article-title":"Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA)","volume":"137","author":"Hofmeijer-Sevink","year":"2012","journal-title":"Journal of Affective Disorders"},{"issue":"11","key":"10.1016\/j.ajp.2012.10.004_bib0095","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4088\/JCP.v59n1107","article-title":"The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine","volume":"59","author":"Keller","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2012.10.004_bib0100","first-page":"872","article-title":"Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression","volume":"163","author":"Klein","year":"1999","journal-title":"American Journal of Proctology"},{"issue":"4","key":"10.1016\/j.ajp.2012.10.004_bib0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.09m05949blu","article-title":"Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials","volume":"72","author":"Levkovitz","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2012.10.004_bib0110","first-page":"15","article-title":"Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide","volume":"18","author":"Pini","year":"2003","journal-title":"International Clinical Psychopharmacology"},{"issue":"11","key":"10.1016\/j.ajp.2012.10.004_bib0115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4088\/JCP.v61n1103","article-title":"Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression","volume":"61","author":"Ravindran","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2012.10.004_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0165-0327(01)00327-5","article-title":"A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder","volume":"70","author":"Rocca","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.ajp.2012.10.004_bib0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-1781(02)00188-9","article-title":"A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes","volume":"112","author":"Rocca","year":"2002","journal-title":"Psychiatry Research"},{"issue":"2\u20133","key":"10.1016\/j.ajp.2012.10.004_bib0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jad.2005.11.014","article-title":"Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine","volume":"91","author":"Serrano-Blanco","year":"2006","journal-title":"Journal of Affective Disorders"},{"issue":"Suppl. 20","key":"10.1016\/j.ajp.2012.10.004_bib0135","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2012.10.004_bib0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00005053-198504000-00001","article-title":"A clinically relevant guide to the differential diagnosis of depression","volume":"173","author":"Sinaikin","year":"1985","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1016\/j.ajp.2012.10.004_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08039480801960123","article-title":"Long-term outcome of patients with dysthymia and panic disorder: a naturalistic 9-year follow-up study","volume":"62","author":"Svanborg","year":"2008","journal-title":"Nordic Journal of Psychiatry"},{"issue":"11","key":"10.1016\/j.ajp.2012.10.004_bib0150","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","article-title":"Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis","volume":"63","author":"Taylor","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1016\/j.ajp.2012.10.004_bib0155","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpsyc.1996.01830090023004","article-title":"A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia","volume":"53","author":"Thase","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.ajp.2012.10.004_bib0160","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/hup.386","article-title":"Onset of action of antidepressants: results of different analyses","volume":"17","author":"Thompson","year":"2002","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.ajp.2012.10.004_bib0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1192\/bjp.170.4.345","article-title":"Controlled efficacy study of fluoxetine in dysthymia","volume":"170","author":"Vanelle","year":"1997","journal-title":"British Journal of Psychiatry"},{"issue":"10","key":"10.1016\/j.ajp.2012.10.004_bib0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00003495-200262040-00010","article-title":"Paroxetine: an update of its use in psychiatric disorders in adults","volume":"62","author":"Wagstaff","year":"2002","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.ajp.2012.10.004_bib0175","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.284.12.1519","article-title":"Treatment of dysthymia and minor depression in primary care: a randomized trial in older adults","volume":"284","author":"Williams","year":"2000","journal-title":"JAMA: The Journal of the American Medical Association"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201812001967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201812001967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:22:26Z","timestamp":1761754946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201812001967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1876201812001967"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2012.10.004","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paroxetine in the treatment of dysthymic disorder without co-morbidities: A double-blind, placebo-controlled, flexible-dose study","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2012.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}